Regression of peripheral and pulmonary rheumatoid nodules under therapy with rituximab;Regression von peripheren und pulmonalen Rheumaknoten unter Rituximab-Therapie

Zeitschrift fur Rheumatologie

Volumn 72, Issue 2, 2013, Pages 166-171

  Braun, M G ^a   Wagener, P ^b  

^a Helios Seehospital Sahlenburg Innere Medizin/Rheumatologie   (Germany)

^b Rheumatologische Praxis ^*  (Germany)

Author keywords

Peripheral rheumatoid nodule; Pulmonary rheumatoid nodule; Regression; Rheumatoid arthritis; Rituximab

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; RITUXIMAB;

ARTICLE; BIOLOGICAL THERAPY; CLINICAL ARTICLE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; LUNG NODULE; MALE; PERIPHERAL RHEUMATOID NODULE; PERIPHERAL RHEUMATOID NODULES; PULMONARY RHEUMATOID NODULE; PULMONARY RHEUMATOID NODULES; REMISSION; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; TREATMENT OUTCOME;

AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG SUBSTITUTION; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LUNG DISEASES; MALE; METHOTREXATE; MIDDLE AGED; PEPTIDES, CYCLIC; RETROSPECTIVE STUDIES; RHEUMATOID FACTOR; RHEUMATOID NODULE; TREATMENT OUTCOME;

EID: 84885188708     PISSN: 03401855     EISSN: 14351250     Source Type: Journal    
DOI: 10.1007/s00393-012-1054-0     Document Type: Article

References (24)

1. Andres M, Vela P, Romera C (2012) Marked improvement of lung rheumatoid nodules after treatment with tocilizumab. Rheumatology 51:1132-1134
2. Baeten D, De Keyser F, Veys EM et al (2004) Tumour necrosis factor ? independent disease mechanisms in rheumatoid arthritis: a histopathological study on the effect of infliximab on rheumatoid nodules. Ann Rheum Dis 63:489-493 (Pubitemid 38530190)
3. Cunnane G, Warnock M, Fye KH et al (2002) Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis. Arthritis Rheum 47:445-449 (Pubitemid 34856135)
4. De Stefano R, Frati E, Nargi L et al (2011) Efficacy of rituximab on pulmonary nodulosis occuring or increasing in patients with rheumatoid arthritis during anti-TNF alpha therapy. Clin Exp Rheumatol 29:752-753
5. García-Patos V (2007) Rheumatoid nodule. Semin Cutan Med Surg 26:100-107 (Pubitemid 46829961)
6. Glace B, Gottenberg J-E, Mariette X et al (2012) Efficacy of rituximab on pulmonary nodules: findings in 10 patients from the French AIR/PR Registry. Ann Rheum Dis 71:1429-1431
7. Highton J, Hung N, Hessian P et al (2007) Pulmonary rheumatoid nodules demonstrating features usually associated with rheumatoid synovial membrane. Rheumatology 46:811-814 (Pubitemid 47061714)
8. Kato H, Yamakawa M, Ogino T (2000) Complement mediated vascular endothelial injury in rheumatoid nodules: a histopathological and immunohistochemical study. J Rheumatol 27:1839-1847 (Pubitemid 30670476)
9. Kekow J, Welte T, Kellner U et al (2002) Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept. Arthritis Rheum 46:843-844 (Pubitemid 34214269)
10. Kerjouan M, Jouneau S, Lena H et al (2011) Pulmonary sarcoidosis developing during treatment with etanercept. Rev Mal Respir 28:360-364
11. Kerstens PJ, Boerbooms AM, Jeurissen ME et al (1992) Accelerated nodulosis during low dose MTX therapy for rheumatoid arthritis: an analysis of ten cases. J Rheumatol 19:67-71
12. Krishna T, Wu P, Rhew E et al (2009) Pulmonary complications of tumor necrosis factor-targeted therapy. Respir Med 103(5):661-669
13. Mackley CL, Ostrov BE, Ioffreda MD (2004) Accelerated cutaneous nodulosis during infliximab therapy in a patient with rheumatoid arthritis. J Clin Rheumatol 10:336-338 (Pubitemid 39612655)
14. Merrill JT, Shen C, Schreibman D et al (1997) Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: a mechanism for methotrexate-induced nodulosis in rheumatoid arthritis. Arthritis Rheum 40:1308-1315 (Pubitemid 27430143)
15. Nannini C, Ryu JU, Matteson EL (2008) Lung disease in rheumatoid arthritis. Curr Opin Rheumatol 20:340-346 (Pubitemid 351483326)
16. Nyhäll-Wåhlin BM, Jacobsson LT, Petersson IF et al (2006) Smoking is a strong risk factor for rheumatoid nodules in early rheumatoid arthritis. Ann Rheum Dis 65:601-606
17. Ognenovski VM, Clark Ojo T, Fox DA (2008) Etanercept-associated pulmonary granulomatous inflammation in patients with rheumatoid arthritis. J Rheumatol 35:2279-2282
18. Oqueka T, Schultz H, Moosig F (2009) Gutes Ansprechen eines pulmonalen Rheumaknoten auf Rituximab. Z Rheumatol 68:343-344
19. Rozin A, Yigla M, Guralnik L et al (2006) Rheumatoid lung nodulosis and osteopathy associated with leflunomide therapy. Clin Rheumatol 25:384-388
20. Scrivo XR, Spadaro A, Iagnocco A et al (2007) Appearance of rheumatoid nodules following anti-tumor necrosis factor ? treatment with adalimumab for rheumatoid arthritis. Clin Exp Rheumatol 25:117 (Pubitemid 46477500)
21. Toussirot E, Berthelot JM, Pertuiset E et al (2009) Pulmonary nodulosis and aseptic granulomatous lung disease occurring in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha-blocking agent: a case series. J Rheumatol 36:2421-2427
22. Turesson C, Jacobsson LT (2004) Epidemiology of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol 33:65-72 (Pubitemid 38437967)
23. Ede A van, Broeder A den, Wagenaar M et al (2007) Etanercept-related extensive pulmonary nodulosis in a patient with rheumatoid arthritis. J Rheumatol 34:1590-1592 (Pubitemid 47068001)
24. Watson P, Simler N, Screaton N et al (2008) Management of accelerated pulmonary nodulosis following etanercept therapy in a patient with rheumatoid arthritis. Rheumatology 47:928-929 (Pubitemid 351796388)